MGMT and glioblastoma: In this retrospective analysis of a multicenter, open-label, phase-3 randomized clinical trial in patients with MGMT promoter-methylated glioblastoma treated with cilengitide, we reviewed MRI data from 545 patients according to the modified RANO criteria.